ResMed Inc (RMD)
243.78
+0.18
(+0.07%)
USD |
NYSE |
Nov 22, 16:00
241.59
-2.19
(-0.90%)
Pre-Market: 20:00
ResMed Free Cash Flow: 1.347B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.347B |
| June 30, 2024 | 1.286B |
| March 31, 2024 | 1.071B |
| December 31, 2023 | 943.73M |
| September 30, 2023 | 792.43M |
| June 30, 2023 | 559.30M |
| March 31, 2023 | 407.69M |
| December 31, 2022 | 221.63M |
| September 30, 2022 | 304.85M |
| June 30, 2022 | 195.11M |
| March 31, 2022 | 343.67M |
| December 31, 2021 | 445.52M |
| September 30, 2021 | 397.18M |
| June 30, 2021 | 619.89M |
| March 31, 2021 | 733.32M |
| December 31, 2020 | 773.77M |
| September 30, 2020 | 683.96M |
| June 30, 2020 | 696.32M |
| March 31, 2020 | 504.78M |
| December 31, 2019 | 419.84M |
| September 30, 2019 | 486.82M |
| June 30, 2019 | 381.71M |
| March 31, 2019 | 373.83M |
| December 31, 2018 | 385.18M |
| September 30, 2018 | 390.37M |
| Date | Value |
|---|---|
| June 30, 2018 | 433.57M |
| March 31, 2018 | 443.58M |
| December 31, 2017 | 360.20M |
| September 30, 2017 | 349.08M |
| June 30, 2017 | 342.58M |
| March 31, 2017 | 349.06M |
| December 31, 2016 | 408.01M |
| September 30, 2016 | 443.53M |
| June 30, 2016 | 480.10M |
| March 31, 2016 | 439.08M |
| December 31, 2015 | 407.57M |
| September 30, 2015 | 353.53M |
| June 30, 2015 | 311.24M |
| March 31, 2015 | 320.43M |
| December 31, 2014 | 323.34M |
| September 30, 2014 | 301.61M |
| June 30, 2014 | 310.11M |
| March 31, 2014 | 321.35M |
| December 31, 2013 | 326.40M |
| September 30, 2013 | 339.65M |
| June 30, 2013 | 331.04M |
| March 31, 2013 | 308.92M |
| December 31, 2012 | 297.33M |
| September 30, 2012 | 317.48M |
| June 30, 2012 | 322.05M |
Free Cash Flow Range, Past 5 Years
195.11M
Minimum
Jun 2022
1.347B
Maximum
Sep 2024
637.38M
Average
589.60M
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Globus Medical Inc | 293.77M |
| Haemonetics Corp | 20.35M |
| Abbott Laboratories | 6.486B |
| Merit Medical Systems Inc | 172.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 325.54M |
| Cash from Investing (Quarterly) | 2.146M |
| Cash from Financing (Quarterly) | -150.76M |
| Free Cash Flow Per Share (Quarterly) | 2.073 |
| Free Cash Flow to Equity (Quarterly) | 335.67M |
| Free Cash Flow to Firm (Quarterly) | 307.28M |
| Free Cash Flow Yield | 3.74% |